Benzinga | Jul 30, 2020 09:07AM EDT

Kiniksa Pharmaceuticals Q2 EPS $(0.65) Up From $(0.68) YoY

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.65) per share. This is a 4.41 percent increase over losses of $(0.68) per share from the same period last year.